Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $642,823,000 | reported | |
| FY 2024 | 2024-12-31 | $610,785,000 | reported | |
| FY 2023 | 2023-12-31 | $618,727,000 | reported | |
| FY 2022 | 2022-12-31 | $516,409,000 | reported | |
| FY 2021 | 2021-12-31 | $490,490,000 | reported | |
| FY 2020 | 2020-12-31 | $298,845,000 | reported | |
| FY 2019 | 2019-12-31 | $245,893,000 | reported | |
| FY 2018 | 2018-12-31 | $146,313,000 | reported | |
| FY 2017 | 2017-12-31 | $71,085,000 | reported |
10x Genomics, Inc. · CIK 1770787 · Engraved from SEC EDGAR
Twelve months to Sep 30, 2026 · derived
10x Genomics, Inc. is the 9th largest of the 25 covered companies the SEC files under this code, by revenue. SIC 3826
Latest filing Nov 16, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2017 | — | $80.00K | $80.00K | — | — | — | — |
493 managers · Quarter ended Sep 30, 2026All holders ›
154